Want to join the conversation?
Pharma company $AGN said it got approval of BYVALSON (nebivolol and valsartan) 5 mg/80 mg tablets, by the US FDA for the treatment of hypertension to lower blood pressure. BYVALSON is the first and only fixed-dose combination of a beta blocker and angiotensin II receptor blocker available in the US. $AGN expects BYVALSON to be available in 2H16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.